Samenvatting
BACKGROUND: Behavior change methods involving new ambulatory technologies may improve lifestyle and cardiovascular disease outcomes. OBJECTIVE: This study aimed to provide proof-of-concept analyses of an intervention aiming to increase (1) behavioral flexibility, (2) lifestyle change, and (3) quality of life. The feasibility and patient acceptance of the intervention were also evaluated. METHODS: Patients with cardiovascular disease (N=149; mean age 63.57, SD 8.30 years; 50/149, 33.5% women) were recruited in the Do Cardiac Health Advanced New Generation Ecosystem (Do CHANGE) trial and randomized to the Do CHANGE intervention or care as usual (CAU). The intervention involved a 3-month behavioral program in combination with ecological momentary assessment and intervention technologies. RESULTS: The intervention was perceived to be feasible and useful. A significant increase in lifestyle scores over time was found for both groups (F2,146.6=9.99; P<.001), which was similar for CAU and the intervention group (F1,149.9=0.09; P=.77). Quality of life improved more in the intervention group (mean 1.11, SD 0.11) than CAU (mean -1.47, SD 0.11) immediately following the intervention (3 months), but this benefit was not sustained at the 6-month follow-up (interaction: P=.02). No significant treatment effects were observed for behavioral flexibility (F1,149.0=0.48; P=.07). CONCLUSIONS: The Do CHANGE 1 intervention was perceived as useful and easy to use. However, no long-term treatment effects were found on the outcome measures. More research is warranted to examine which components of behavioral interventions are effective in producing long-term behavior change. TRIAL REGISTRATION: ClinicalTrials.gov NCT02946281; https://www.clinicaltrials.gov/ct2/show/NCT02946281.
Originele taal-2 | Engels |
---|---|
Artikelnummer | e14570 |
Aantal pagina's | 12 |
Tijdschrift | Journal of Medical Internet Research |
Volume | 22 |
Nummer van het tijdschrift | 5 |
DOI's | |
Status | Gepubliceerd - 22 mei 2020 |
Financiering
The authors would like to thank all the patients for participating and the health care professionals in the participating hospitals for making this work possible. In addition, the authors would like to thank all the students/research assistants for their help with the patient recruitment and data management. Finally, the authors want to thank the consortium members of the Do CHANGE project. This study was funded by the European Commission’s Horizon 2020 program (grant number: 463735). For this project, the Do CHANGE team received funding for research and innovation from the European Union. One startup (Onmi) and 2 small-and medium-sized enterprises (DSD, Docobo Ltd) are supported financially to develop their products. The authors would like to thank all the patients for participating and the health care professionals in the participating hospitals for making this work possible. In addition, the authors would like to thank all the students/research assistants for their help with the patient recruitment and data management. Finally, the authors want to thank the consortium members of the Do CHANGE project. This study was funded by the European Commission's Horizon 2020 program (grant number: 463735). For this project, the Do CHANGE team received funding for research and innovation from the European Union. One startup (Onmi) and 2 small- and medium-sized enterprises (DSD, Docobo Ltd) are supported financially to develop their products.
Financiers | Financiernummer |
---|---|
European Union’s Horizon Europe research and innovation programme | |
European Union’s Horizon Europe research and innovation programme | 463735 |
European Commission |